Target intelligence / Profile preview

Intestinal sugar absorption

Molecular classification
Other (physiological process, not a single molecular entity), Transporters (refers to SGLT1, GLUT2, GLUT5)
01

Overview

Intestinal sugar absorption refers to the process by which dietary monosaccharides—primarily glucose, galactose, and fructose—are transported across the intestinal epithelium into the bloodstream. The classic model describes SGLT1 as the major apical (brush-border) Na^+/glucose cotransporter responsible for active glucose and galactose uptake, while GLUT5 mediates fructose absorption. GLUT2 is conventionally the basolateral transporter for exit into blood, but at high luminal glucose/fructose loads, GLUT2 can translocate to the apical membrane, enabling facilitated diffusion and accelerating absorption. These pathways are upregulated in diabetes, contributing to hyperglycemia and have become targets for experimental pharmacological intervention[1][2][3][4][5].

Other names
Carbohydrate absorptionSugar transport in intestineIntestinal carbohydrate uptake
02

Mechanism of action

Inhibition of SGLT1 decreases glucose uptake in the small intestine, lowering postprandial blood sugar\nInhibition of GLUT2 may limit bulk glucose and fructose absorption at high luminal concentrations

03

Biological functions

Absorption of dietary carbohydratesRegulation of blood glucose levelsNutrient sensing
04

Disease associations

DiabetesObesityMalabsorption syndromesMetabolic syndrome
05

Safety considerations

Potential gastrointestinal side effects (bloating, diarrhea) from impaired sugar absorptionMalabsorption leading to osmotic diarrhea when these transporters are inhibited or defective
06

Interacting drugs

SGLT1 inhibitors (experimental, e.g., phloridzin[3])

2 more in the full profile.

07

Biomarkers

Expression levels of SGLT1, GLUT2, and GLUT5 in intestinal tissueOral glucose tolerance test (OGTT) responses

Beyond the preview

Go deeper on Intestinal sugar absorption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal sugar absorption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call